Prisys is the leading innovator in non-human primate disease modeling based on the capstone platform along with global innovation-centered collaborations, delivering never before solidified data package of translational science and transformational technologies for new medicine and therapeutics in advancement.

The translational medicine calls for the meaningful connections, with both more direct bidirectional and translatable means, to minimize the gap between research and clinic. Prisys has never before in the world established a new and integrated NHP platform composed of NHP disease models, relevant clinical diagnosis, procedures, treatment, and measurements for global pharmas’ advancement of new medicines and biotechnologies. It surpasses the rodents or the ex-patient materials by bringing in more systemic and interpretable results to support more direct translation and prediction of the applications in human.